By Abbott Labs
Report updated Jun 10, 2026
Libre by Abbott
For diabetes patients (ages 2+) and their caregivers or healthcare providers.
Libre by Abbott is an established medical app that is completely free. With a 4.5/5 rating from 126.1K reviews, it shows polarized user reception. Users particularly appreciate real-time glucose monitoring provides freedom from manual finger-prick testing throughout the day, though frequent bluetooth connection drops between the sensor and mobile device disrupt continuous data tracking remains a common concern.
What is Libre by Abbott?
Libre by Abbott is a continuous glucose monitoring app for diabetes patients, serving as a companion tool for proprietary hardware sensors on iOS and Android.
Users hire the app to automate glucose tracking and eliminate manual finger-prick testing, shifting the burden of care from active logging to passive, real-time data monitoring.
Current Momentum
v1.2
- Shipped Libre Assist AI food prediction.
- Enabled direct smartwatch glucose readings.
Active Nemesis
mySugr - Diabetes Tracker Log
By mySugr
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalRating Pulse 🇺🇸
Recent User MoodAI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.
What makes this app unique?
What Does It Look Like?
How Is The App's Momentum Right Now?
Loading...
What Are The Key Features?
Generative AI food impact prediction
Automatic glucose readings every minute
Remote data sharing for caregivers
How much does it cost?
- Free app
- Prescription-only sensors
The app functions as a free utility to drive recurring revenue from prescription-only sensor hardware.
Who Built It?
Abbott Labs
Providing digital health tools for continuous glucose monitoring. Enabling patients to track glucose trends via smartphone integration.
Portfolio
13
Apps
Who is Abbott Labs?
Abbott Labs operates as a specialized medical technology provider, leveraging proprietary hardware-software integration to maintain a dominant position in the diabetes management market. Their strategic moat is built on the mandatory pairing of their mobile applications with specific, regulated glucose-sensing hardware, creating high switching costs for the end user. The current trajectory is defined by a critical technical inflection point, as recent performance issues on newer iOS versions threaten the stability of their primary digital touchpoints.
Who is Abbott Labs for?
- Individuals with diabetes
- Their caregivers requiring real-time glucose data
- Trend analysis
Portfolio momentum
Released 4 updates across 3 apps in the last 6 months, maintaining a consistent focus on their core medical monitoring suite.
What other apps does Abbott Labs make?
FreeStyle Libre 3 – US
FreeStyle LibreLink – ZA
FreeStyle LibreLink – BE
FreeStyle LibreLink – KW
FreeStyle Libre 3 - CH
FreeStyle Libre 3 - AT
What do users think recently?
High confidence · 49 reviews analyzed
How did the latest release land?
What is the recent mood?
Recent user voice shows a mixed sentiment. Users appreciate real-time glucose monitoring provides freedom from manual finger-prick testing throughout the day, but report frequent bluetooth connection drops between the sensor and mobile device disrupt continuous data tracking.
Limited review volume (49 reviews). Sentiment analysis will deepen as more data lands.
What is the competitive landscape for Libre by Abbott?
How's The Medical Market?
How does it evolve in the Medical market?
Libre by Abbott currently holds the #12 spot in the US Medical category. The gap between its high-utility sensor hardware and the mixed sentiment on connectivity suggests that market share is currently defended by hardware lock-in rather than software satisfaction.
| Country | Category | Chart | Rank | Change |
|---|---|---|---|---|
| 🇺🇸 US | Medical | AndroidFree | #11 | ▼1 |
| 🇺🇸 US | Medical | iOSFree | #22 |
The rivals identified
The Nemesis
mySugr - Diabetes Tracker Log
★4.5 (134.1K)mySugr GmbH
⚡With over 134,000 reviews and a high release cadence, mySugr is the primary competitor for user engagement in the diabetes management space.
Head to Head
The target app must decide whether to remain a pure sensor-companion or expand into a holistic diabetes management platform to compete with mySugr's engagement-focused ecosystem.
What sets Libre by Abbott apart
Direct, real-time data streaming from proprietary sensors provides a more seamless user experience than manual logging.
Clinical-grade data presentation focuses on glucose trends without the distraction of gamification elements.
What's mySugr - Diabetes Tracker Log's Edge
Gamified logging interface significantly improves long-term user retention and daily habit formation for patients.
Broad hardware compatibility allows users to aggregate data from multiple sources into a single dashboard.
Contenders
Includes a robust community forum for peer support which is absent in the target app.
Offers extensive reporting tools that allow users to export data for physician review in multiple formats.
Dexcom G7
★3.3 (12.2K)Dexcom
⚡As a direct competitor in the CGM hardware space, Dexcom G7 is the primary alternative for users choosing between sensor ecosystems.
Hardware-integrated alert system offers more granular customization for glucose thresholds than the target app.
Direct integration with insulin delivery systems provides a closed-loop experience that the target currently lacks.
OneTouch Reveal® app
★4.8 (158K)LifeScan, Inc.
📈A long-standing competitor in the diabetes space with a massive user base and high-quality clinical data visualization.
Visualizes high-glucose patterns over time to help users identify specific lifestyle triggers more effectively.
Color-coded dashboard provides immediate, at-a-glance status updates for patients and their healthcare providers.
Peers
Advanced medication reminder system includes family notification features for missed doses, increasing patient safety.
Cross-condition tracking allows users to manage multiple chronic conditions alongside their diabetes management.
Kardia
★4.8 (210.9K)AliveCor, Inc.
⚡High-utility medical app that demonstrates how to successfully pair hardware with a high-engagement mobile interface.
Provides instant clinical-grade ECG analysis that sets a high bar for medical hardware-app integration.
Subscription-based premium insights model offers a clear path for monetization beyond the free app tier.
New Kids on the Block
Utilizes AI-driven motion tracking to provide real-time feedback during physical therapy sessions.
Personalized care plans adapt dynamically based on user performance data collected during each session.
One Medical
★4.9 (52.7K)One Medical Group, Inc.
⚡Rapidly evolving platform that bridges the gap between digital tracking and direct access to clinical care.
Integrates virtual primary care consultations directly into the app, bypassing the need for separate telehealth apps.
Unified health record access allows users to view lab results and clinical notes alongside their own tracking.
The outtake for Libre by Abbott
Strengths to defend, gaps to attack
Core Strengths
- Proprietary sensor-hardware integration creates high switching costs
- LibreView clinical data management drives provider-led prescription volume
Critical Frictions
- Frequent Bluetooth connection drops
- Lack of Apple Health data syncing
- 0.7★ Android-iOS rating gap
Growth Levers
- Untapped education partnerships for B2B distribution
- Integration of insulin delivery systems for closed-loop management
Market Threats
- mySugr's gamified retention loops
- Dexcom G7's superior alert customization
- OS update incompatibility cycles
What are the next best moves?
Rebuild Bluetooth handshake logic because connection drops are the #1 complaint theme → reduce churn
Bluetooth connection drops are the primary driver of negative sentiment in the latest version.
Trade-off: Pause the Libre Assist feature expansion — connectivity stability is a prerequisite for user trust.
Ship Apple Health integration because it is a top-requested feature → improve platform stickiness
Users cite lack of native data syncing as a primary frustration in reviews.
Trade-off: Deprioritize the smartwatch widget development — native health ecosystem integration has higher user-retention value.
A counter-intuitive read
The app's #12 chart position is a liability, not a win: maintenance-mode at the top of the category leaves the platform vulnerable to a single, stable-connection rival.
Feature Gaps vs Competitors
- Gamified logging (available in mySugr)
- Insulin delivery system integration (available in Dexcom G7)
Key Takeaways
Libre by Abbott maintains its category lead through proprietary hardware, but technical instability in the latest version threatens long-term retention, so the PM must prioritize Bluetooth reliability over new AI features to prevent user migration to more stable competitors.
Where Is It Heading?
Mixed Signals
The diabetes management market is shifting toward closed-loop systems that prioritize data reliability over standalone tracking. Libre by Abbott remains advantaged by its sensor ecosystem, but the current technical friction creates an opening for rivals to capture the power-user segment.
Persistent Bluetooth connectivity failures in the latest version disrupt data tracking, which compounds the rating drag already visible on Android.
The addition of Libre Assist AI indicates active feature investment, which differentiates the app from purely manual logging competitors.